Ekso Bionics Holdings Inc (EKSO)

[Rhetorical]

With operating expenses staying constant, revenue needs to go up nearly 370% before a net even.

This is based on the Q3 2018 report:

Revenues of $2.6 million for the quarter ended September 30, 2018

Net loss applicable to common stockholders for the quarter ended September 30, 2018 was $7.0 million

Thus revenues need to hit 9.6 million before there is no net loss, ~370% of 2.6 million

So while 60% revenue growth is nothing to scoff at, a big contract with the VA or DoD could net 7 million in one swoop